Hepatitis B in patients with hematological diseases: An update.

World J Hepatol · 2017 · PMC5596311 · PMID 28951776

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

clearly significantno p-value reported

For HBsAg positive patients with hematological malignancies the risk of reactivation emerges to be clearly significant (24%-88%, median 50%), and the particular increase of HBVr associated with the use of RTX has been definitely stated.

also in 627 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.